dc.contributor.author |
Schneidawind, Dominik |
|
dc.contributor.author |
Dürr-Störzer, Silke |
|
dc.contributor.author |
Liewer, Sonja |
|
dc.contributor.author |
Renner, Susanne |
|
dc.contributor.author |
Navarro, Beatriz Sanchez |
|
dc.contributor.author |
Atar, Daniel |
|
dc.contributor.author |
Keppeler, Hildegard |
|
dc.contributor.author |
Beck, Robert |
|
dc.contributor.author |
Hamprecht, Klaus |
|
dc.contributor.author |
Kanz, Lothar |
|
dc.contributor.author |
Lengerke, Claudia |
|
dc.contributor.author |
Schneidawind, Corina |
|
dc.date.accessioned |
2023-06-07T09:45:10Z |
|
dc.date.available |
2023-06-07T09:45:10Z |
|
dc.date.issued |
2022 |
|
dc.identifier.issn |
2666-6375 |
|
dc.identifier.uri |
http://hdl.handle.net/10900/141965 |
|
dc.language.iso |
en |
en |
dc.publisher |
Elsevier Science Inc |
de_DE |
dc.relation.uri |
http://dx.doi.org/10.1016/j.jtct.2022.05.011 |
|
dc.subject.ddc |
610 |
de_DE |
dc.subject.ddc |
570 |
de_DE |
dc.title |
Low Graft Invariant Natural Killer T-Cell Dose Is a Risk Factor for Cytomegalovirus Reactivation After Allogeneic Hematopoietic Cell Transplantation |
de_DE |
dc.type |
Article |
de_DE |
utue.quellen.id |
20230202000000_02111 |
|
utue.personen.roh |
Schneidawind, Dominik |
|
utue.personen.roh |
Duerr-Stoerzer, Silke |
|
utue.personen.roh |
Liewer, Sonja |
|
utue.personen.roh |
Renner, Susanne |
|
utue.personen.roh |
Navarro, Beatriz Sanchez |
|
utue.personen.roh |
Atar, Daniel |
|
utue.personen.roh |
Keppeler, Hildegard |
|
utue.personen.roh |
Beck, Robert |
|
utue.personen.roh |
Hamprecht, Klaus |
|
utue.personen.roh |
Kanz, Lothar |
|
utue.personen.roh |
Lengerke, Claudia |
|
utue.personen.roh |
Schneidawind, Corina |
|
dcterms.isPartOf.ZSTitelID |
Transplantation and Cellular Therapy |
de_DE |
dcterms.isPartOf.ZS-Issue |
8 |
de_DE |
dcterms.isPartOf.ZS-Volume |
28 |
de_DE |
utue.fakultaet |
04 Medizinische Fakultät |
|